136 related articles for article (PubMed ID: 33129760)
1. Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor Suppressor, Induces G2/M Cell Cycle Checkpoint Arrest in Colon Cancer Cells.
De La Cena KOC; Ho RX; Amraei R; Woolf N; Tashjian JY; Zhao Q; Richards S; Walker J; Huang J; Chitalia VC; Rahimi N
Am J Pathol; 2021 Jan; 191(1):157-167. PubMed ID: 33129760
[TBL] [Abstract][Full Text] [Related]
2. The Role of TMIGD1 as a Tumor Suppressor in Colorectal Cancer.
Mu L; Wang Y; Hu Y; Shi C; Alman BA; Zhang C; She J
Genet Test Mol Biomarkers; 2022 Apr; 26(4):174-183. PubMed ID: 35481970
[No Abstract] [Full Text] [Related]
3. The cell adhesion molecule TMIGD1 binds to moesin and regulates tubulin acetylation and cell migration.
Rahimi N; Ho RXY; Chandler KB; De La Cena KOC; Amraei R; Mitchel AJ; Engblom N; Costello CE
J Biomed Sci; 2021 Sep; 28(1):61. PubMed ID: 34503512
[TBL] [Abstract][Full Text] [Related]
4. TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer.
Meyer RD; Zou X; Ali M; Ersoy E; Bondzie PA; Lavaei M; Alexandrov I; Henderson J; Rahimi N
Oncotarget; 2018 Feb; 9(11):9672-9684. PubMed ID: 29515762
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria.
Hartmann C; Schwietzer YA; Kummer D; Kirschnick N; Hoppe E; Thüring EM; Glaesner-Ebnet M; Brinkmann F; Gerke V; Reuter S; Nakayama M; Ebnet K
BMC Mol Cell Biol; 2020 Apr; 21(1):30. PubMed ID: 32303178
[TBL] [Abstract][Full Text] [Related]
6. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.
Li VS; Yuen ST; Chan TL; Yan HH; Law WL; Yeung BH; Chan AS; Tsui WY; So S; Chen X; Leung SY
Gastroenterology; 2009 Jul; 137(1):176-87. PubMed ID: 19303019
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
Hong YS; Hong SW; Kim SM; Jin DH; Shin JS; Yoon DH; Kim KP; Lee JL; Heo DS; Lee JS; Kim TW
Int J Oncol; 2012 Jul; 41(1):76-82. PubMed ID: 22552540
[TBL] [Abstract][Full Text] [Related]
8. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.
Hoshiko S; Kawaguchi M; Fukushima T; Haruyama Y; Yorita K; Tanaka H; Seiki M; Inatsu H; Kitamura K; Kataoka H
Cancer Res; 2013 Apr; 73(8):2659-70. PubMed ID: 23447577
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.
Liu S; Liu B
Med Sci Monit; 2018 Mar; 24():1424-1433. PubMed ID: 29519997
[TBL] [Abstract][Full Text] [Related]
11. TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury.
Arafa E; Bondzie PA; Rezazadeh K; Meyer RD; Hartsough E; Henderson JM; Schwartz JH; Chitalia V; Rahimi N
Am J Pathol; 2015 Oct; 185(10):2757-67. PubMed ID: 26342724
[TBL] [Abstract][Full Text] [Related]
12. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.
Jiang L; Yang S; Yin H; Fan X; Wang S; Yao B; Pozzi A; Chen X; Harris RC; Zhang MZ
Mol Cancer Res; 2013 Sep; 11(9):1040-50. PubMed ID: 23741059
[TBL] [Abstract][Full Text] [Related]
14. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
[TBL] [Abstract][Full Text] [Related]
15. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease.
Zhou L; Zhu L; Wu X; Hu S; Zhang S; Ning M; Yu J; Chen M
BMC Med; 2023 Aug; 21(1):287. PubMed ID: 37542259
[TBL] [Abstract][Full Text] [Related]
16. ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
Neilsen BK; Frodyma DE; McCall JL; Fisher KW; Lewis RE
PLoS One; 2019; 14(1):e0209224. PubMed ID: 30629587
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
18. CKIα ablation highlights a critical role for p53 in invasiveness control.
Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
[TBL] [Abstract][Full Text] [Related]
19. NCAPH plays important roles in human colon cancer.
Yin L; Jiang LP; Shen QS; Xiong QX; Zhuo X; Zhang LL; Yu HJ; Guo X; Luo Y; Dong J; Kong QP; Yang CP; Chen YB
Cell Death Dis; 2017 Mar; 8(3):e2680. PubMed ID: 28300828
[TBL] [Abstract][Full Text] [Related]
20. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
